134 related articles for article (PubMed ID: 26550280)
1. The effect of prediagnostic aspirin use on the prognosis of stage III colorectal cancer.
Kim B; Park SJ; Hong SP; Cheon JH; Kim WH; Kim TI
Int J Clin Exp Med; 2015; 8(8):13435-45. PubMed ID: 26550280
[TBL] [Abstract][Full Text] [Related]
2. Post-operative aspirin use and colorectal cancer-specific survival in patients with stage I-III colorectal cancer.
Goh CH; Leong WQ; Chew MH; Pan YS; Tony LK; Chew L; Tan IB; Toh HC; Tang CL; Fu WP; Chia WK
Anticancer Res; 2014 Dec; 34(12):7407-14. PubMed ID: 25503181
[TBL] [Abstract][Full Text] [Related]
3. Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer.
Coghill AE; Newcomb PA; Campbell PT; Burnett-Hartman AN; Adams SV; Poole EM; Potter JD; Ulrich CM
Gut; 2011 Apr; 60(4):491-8. PubMed ID: 21051449
[TBL] [Abstract][Full Text] [Related]
4. Prediagnostic use of low-dose aspirin and risk of incident metastasis and all-cause mortality among patients with colorectal cancer.
Giorli G; Rouette J; Yin H; Lapi F; Simonetti M; Cricelli C; Pollak M; Azoulay L
Br J Clin Pharmacol; 2020 Nov; 86(11):2266-2273. PubMed ID: 32352592
[TBL] [Abstract][Full Text] [Related]
5. Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Bradley MC; Black A; Freedman AN; Barron TI
Cancer; 2016 Jul; 122(13):2067-75. PubMed ID: 27149646
[TBL] [Abstract][Full Text] [Related]
6. Common colorectal cancer risk variants in SMAD7 are associated with survival among prediagnostic nonsteroidal anti-inflammatory drug users: a population-based study of postmenopausal women.
Passarelli MN; Coghill AE; Hutter CM; Zheng Y; Makar KW; Potter JD; Newcomb PA
Genes Chromosomes Cancer; 2011 Nov; 50(11):875-86. PubMed ID: 21910156
[TBL] [Abstract][Full Text] [Related]
7. Associations of Aspirin and Non-Aspirin Non-Steroidal Anti-Inflammatory Drugs With Colorectal Cancer Mortality After Diagnosis.
Figueiredo JC; Jacobs EJ; Newton CC; Guinter MA; Cance WG; Campbell PT
J Natl Cancer Inst; 2021 Jul; 113(7):833-840. PubMed ID: 33528005
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer after start of nonsteroidal anti-inflammatory drug use.
Stürmer T; Buring JE; Lee IM; Kurth T; Gaziano JM; Glynn RJ
Am J Med; 2006 Jun; 119(6):494-502. PubMed ID: 16750963
[TBL] [Abstract][Full Text] [Related]
9. The relationship between aspirin use and mortality in colorectal cancer.
Albandar HJ; Markert R; Agrawal S
J Gastrointest Oncol; 2018 Dec; 9(6):1133-1137. PubMed ID: 30603132
[TBL] [Abstract][Full Text] [Related]
10. Pre-diagnosis and post-diagnosis use of common analgesics and ovarian cancer prognosis (NHS/NHSII): a cohort study.
Merritt MA; Rice MS; Barnard ME; Hankinson SE; Matulonis UA; Poole EM; Tworoger SS
Lancet Oncol; 2018 Aug; 19(8):1107-1116. PubMed ID: 30029888
[TBL] [Abstract][Full Text] [Related]
11. The 15-lipoxygenase-1 expression may enhance the sensitivity to non-steroidal anti-inflammatory drug-induced apoptosis in colorectal cancers from patients who are treated with the compounds.
Yoshinaga M; Murao H; Kitamura Y; Koga K; Tsuruta S; Igarashi H; Nakamura K; Takayanagi R
J Gastroenterol Hepatol; 2007 Dec; 22(12):2324-9. PubMed ID: 17559385
[TBL] [Abstract][Full Text] [Related]
12. Do Aspirin and Other NSAIDs Confer a Survival Benefit in Men Diagnosed with Prostate Cancer? A Pooled Analysis of NIH-AARP and PLCO Cohorts.
Zhou CK; Daugherty SE; Liao LM; Freedman ND; Abnet CC; Pfeiffer R; Cook MB
Cancer Prev Res (Phila); 2017 Jul; 10(7):410-420. PubMed ID: 28507039
[TBL] [Abstract][Full Text] [Related]
13. Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: a Danish cohort study.
Friis S; Poulsen AH; Sørensen HT; Tjønneland A; Overvad K; Vogel U; McLaughlin JK; Blot WJ; Olsen JH
Cancer Causes Control; 2009 Jul; 20(5):731-40. PubMed ID: 19122977
[TBL] [Abstract][Full Text] [Related]
14. Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer.
Okuda Y; Shimura T; Yamada T; Hirata Y; Yamaguchi R; Sakamoto E; Kataoka H
Int J Clin Oncol; 2018 Dec; 23(6):1101-1111. PubMed ID: 29948240
[TBL] [Abstract][Full Text] [Related]
15. Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence.
Cronin-Fenton DP; Heide-Jørgensen U; Ahern TP; Lash TL; Christiansen P; Ejlertsen B; Sørensen HT
Epidemiology; 2016 Jul; 27(4):586-93. PubMed ID: 27007644
[TBL] [Abstract][Full Text] [Related]
16. Examining the impact of regular aspirin use and PIK3CA mutations on survival in stage 2 colon cancer.
Murphy C; Turner N; Wong HL; Sinnathamby M; Tie J; Lee B; Desai J; Skinner I; Christie M; Hutchinson R; Lunke S; Waring P; Gibbs P; Tran B
Intern Med J; 2017 Jan; 47(1):88-98. PubMed ID: 27800646
[TBL] [Abstract][Full Text] [Related]
17. Association of Aspirin and Nonsteroidal Anti-Inflammatory Drugs With Colorectal Cancer Risk by Molecular Subtypes.
Amitay EL; Carr PR; Jansen L; Walter V; Roth W; Herpel E; Kloor M; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
J Natl Cancer Inst; 2019 May; 111(5):475-483. PubMed ID: 30388256
[TBL] [Abstract][Full Text] [Related]
18. NSAID and aspirin use by the elderly in general practice: effect on gastrointestinal symptoms and therapies.
Pilotto A; Franceschi M; Leandro G; Di Mario F;
Drugs Aging; 2003; 20(9):701-10. PubMed ID: 12831293
[TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.
Marshall SF; Bernstein L; Anton-Culver H; Deapen D; Horn-Ross PL; Mohrenweiser H; Peel D; Pinder R; Purdie DM; Reynolds P; Stram D; West D; Wright WE; Ziogas A; Ross RK
J Natl Cancer Inst; 2005 Jun; 97(11):805-12. PubMed ID: 15928301
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
